Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.

Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.

Item
http://www.wikidata.org/entity/Q34158063
Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetesDecreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease.Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients.Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trialResistin: functional roles and therapeutic considerations for cardiovascular disease.Adiponectin, diabetes and ischemic heart failure: a challenging relationship.Transcatheter Arterial Infusion of Autologous CD133(+) Cells for Diabetic Peripheral Artery Disease.Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome.Inflammation: therapeutic targets for diabetic neuropathy.Identifying Common Genetic Risk Factors of Diabetic Neuropathies.Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study.Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men.The ubiquitous interleukin-6: a time for reappraisal.Associations among physical activity, comorbidities, depressive symptoms and health-related quality of life in type 2 diabetes.Diabetes and Sepsis: Risk, Recurrence, and Ruination.Network Analysis of MPO and Other Relevant Proteins Involved in Diabetic Foot Ulcer and Other Diabetic Complications.
P2860

Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.

Item
http://www.wikidata.org/entity/Q34158063
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@ast
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@en
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@nl
type
label
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@ast
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@en
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@nl
prefLabel
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@ast
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@en
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Adiponectin, resistin and IL-6 ...... d cardiovascular co-morbidity.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932